Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 2
1991 1
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 7
1999 7
2000 7
2001 11
2002 1
2003 7
2004 3
2005 6
2006 3
2007 2
2009 3
2010 3
2011 3
2012 3
2013 1
2014 2
2015 4
2017 3
2018 4
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10585987

92 results
Results by year
Filters applied: . Clear all
Page 1
Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.
Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Marshall DD, et al. Pediatrics. 1999 Dec;104(6):1345-50. doi: 10.1542/peds.104.6.1345. Pediatrics. 1999. PMID: 10585987
Population-based study of chronic lung disease in very low birth weight infants in North Carolina in 1994 with comparisons with 1984. The North Carolina Neonatologists Association.
Young TE, Kruyer LS, Marshall DD, Bose CL. Young TE, et al. Pediatrics. 1999 Aug;104(2):e17. doi: 10.1542/peds.104.2.e17. Pediatrics. 1999. PMID: 10429135
Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS, Ohlsson A, Halliday H, Shah VS. Shah SS, et al. Cochrane Database Syst Rev. 2003;(1):CD002058. doi: 10.1002/14651858.CD002058. Cochrane Database Syst Rev. 2003. PMID: 12535425 Updated. Review.
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.
Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Rojas MA, et al. J Pediatr. 1995 Apr;126(4):605-10. doi: 10.1016/s0022-3476(95)70362-4. J Pediatr. 1995. PMID: 7699543
Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
Vermont Oxford Network Steroid Study Group. Vermont Oxford Network Steroid Study Group. Pediatrics. 2001 Sep;108(3):741-8. doi: 10.1542/peds.108.3.741. Pediatrics. 2001. PMID: 11533345 Clinical Trial.
Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era.
Perzigian RW, Adams JT, Weiner GM, Dipietro MA, Blythe LK, Pierson CL, Faix RG. Perzigian RW, et al. Pediatr Infect Dis J. 1998 Jul;17(7):620-5. doi: 10.1097/00006454-199807000-00009. Pediatr Infect Dis J. 1998. PMID: 9686729
Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS, Ohlsson A, Halliday H, Shah VS. Shah SS, et al. Cochrane Database Syst Rev. 2003;(2):CD002057. doi: 10.1002/14651858.CD002057. Cochrane Database Syst Rev. 2003. PMID: 12804423 Updated. Review.
Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V, Ohlsson A, Halliday HL, Dunn MS. Shah V, et al. Cochrane Database Syst Rev. 2000;(2):CD001969. doi: 10.1002/14651858.CD001969. Cochrane Database Syst Rev. 2000. PMID: 10796275 Updated. Review.
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.
Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Van Marter LJ, et al. Pediatrics. 2000 Jun;105(6):1194-201. doi: 10.1542/peds.105.6.1194. Pediatrics. 2000. PMID: 10835057
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.
Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M; Neonatology Committee for the Developmental Epidemiology Network. Van Marter LJ, et al. J Pediatr. 2001 Feb;138(2):198-204. doi: 10.1067/mpd.2001.110980. J Pediatr. 2001. PMID: 11233077
92 results
Jump to page
Feedback